According to Futu News on June 28, Hong Kong stocks opened low today, and the three major indexes fluctuated in a narrow range. As of press time, the Hang Seng Index fell nearly 1%, and the Science Index fell nearly 2%. On the disk, most of cloud computing, mobile games and other stocks weakened, while electric power stocks, gas stocks, coal stocks and other plates rose.

Most of the science and Internet stocks fell, Tencent fell nearly 5%, BABA and Meituan fell more than 2%, JD.com fell more than 4%, XIAOMI rose more than 1% against the market.

Coal stocks rose, with China Coal Energy up nearly 5 per cent, Yanzhou Mining Energy up nearly 4 per cent, China Shenhua Energy up more than 2 per cent and Shougang Resources up more than 1 per cent.

Gas stocks rose generally, China Gas nearly 11%, Kunlun Energy nearly 4%, China Resources Gas more than 3%, ENN Energy and Tianlun Gas up more than 2%. According to Xinhuanet, the General Office of the Ministry of Housing and Urban-Rural Development and the General Office of the National Development and Reform Commission issued a notice on the 27th, requiring all localities to carry out scientific and orderly assessment of the aging of urban gas pipelines, plants, stations, and facilities, and to prioritize according to the assessment results, and immediately transform pipelines and facilities with serious safety risks.

Oil stocks rose, with CNOOC Limited up more than 3 per cent, China Petroleum & Chemical Corporation, Petrochina and China Oilfield Services up more than 1 per cent.

Pharmaceutical stocks fell, Wuxi Biologics and Wuxi Apptec fell more than 4%, Pharmaron Beijing Co., Ltd.* fell nearly 4%, Zhaoyan new drugs, Genscript Biotech Corporation fell more than 2%.

Tencent fell more than 5%, Daiwa and other institutions issued a research report to reiterate Tencent's "buy" rating. This reduction is a normal financial arrangement for major shareholders, short-term market sentiment may be suppressed, and Tencent's long-term fundamentals remain optimistic.

Clover biology rose nearly 22%, and the company's COVID-19 vaccine candidate showed a strong cross-neutralization effect on Omicron as a homologous strengthening needle.

Gome Retail fell by more than 14%. The company entered into placing agreements with placing agents and sellers for placing and subscription, trying to place 1.96 billion existing shares at a placing price of HK $0.40 per share, with an estimated net income of HK $776.5 million.